Vir Biotechnology lands a license agreement with Japan’s Astellas Pharma for its lead drug candidate.

Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. When it comes to biotech ETFs, they give sector participants exposure to many biotech companies via one ...

In this piece, we discuss the 10 Best Small-Cap Biotech Stocks to Buy According to Analysts. Small-cap biotech stocks are marking their latest resurgence, attracting renewed investor attention. This ...

Both Ironwood Pharmaceuticals IRWD and Puma Biotechnology PBYI are small biotechs, concentrating on the successful commercialization of their respective products with the goal of establishing ...

CorMedix CRMD and Puma Biotechnology PBYI are small-cap biotech companies focused on the successful commercialization of their core products as they work to establish leadership within their ...

State Street strategist Michael Arone thinks 2026 will deliver unexpected things for investors—including a strong run for ...

The green shoots suggesting a comeback was in sight for biotech stocks last year have mostly grown into proverbial flowering plants—but one company’s precipitous year-over-year decline in market ...